Ovid Therapeutics Inc. (FRA:1OT)

Ovid Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	110	64	206	123	192	120
Market Cap Growth	34.60%	-68.90%	67.89%	-36.19%	60.44%	-32.26%
Enterprise Value	100	18	142	9	15	49
Last Close Price	1.47	0.89	3.00	1.68	2.74	1.83
PE Ratio	-	-	-	-	1.82	-
PS Ratio	19.57	117.14	580.59	87.22	1.05	11.61
PB Ratio	2.89	0.97	2.59	0.99	1.22	3.36
P/TBV Ratio	2.89	0.97	2.60	0.99	1.22	3.38
P/FCF Ratio	-	-	-	-	1.85	-
P/OCF Ratio	-	-	-	-	1.84	-
EV/Sales Ratio	17.60	32.98	400.05	6.30	0.08	4.73
EV/EBITDA Ratio	-	-	-	-	0.14	-
EV/EBIT Ratio	-	-	-	-	0.14	-
EV/FCF Ratio	-3.09	-	-	-	0.14	-
Debt / Equity Ratio	0.31	0.22	0.18	0.13	-	-
Asset Turnover	0.08	0.01	0.00	0.01	1.54	0.16
Quick Ratio	3.77	5.04	9.23	18.45	12.69	3.27
Current Ratio	4.24	5.32	9.55	18.79	12.87	3.39
Return on Equity (ROE)	-60.06%	-33.88%	-47.57%	-34.72%	109.98%	-142.60%
Return on Assets (ROA)	-29.33%	-30.90%	-24.05%	-19.85%	57.40%	-64.93%
Return on Capital (ROIC)	-32.59%	-39.07%	-28.49%	-21.13%	69.51%	-89.56%
Return on Capital Employed (ROCE)	-68.50%	-71.50%	-43.40%	-37.50%	69.10%	-151.20%
Earnings Yield	-27.73%	-39.87%	-23.00%	-41.33%	56.20%	-55.30%
FCF Yield	-29.34%	-84.50%	-20.13%	-43.07%	54.18%	-35.29%
Buyback Yield / Dilution	-0.35%	-0.46%	-0.22%	-3.46%	-16.45%	-49.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.